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Tumorigenesis in vivo is a  important indication of malignant conversion of 
cells  "transformed"  in vitro  by either chemical, physical,  or viral means. A 
clonal line of nonproducer (NP) 1 cells which was derived from BALB/3T3 cells 
transformed  by  the  Kirsten  strain  of  murine  sarcoma  virus  (Ki-MSV),  is 
tumorigenic when  the  cells  are  inoculated into syngeneic BALB/c  mice  (1). 
With this NP line serving as progenitor, we selected morphological variants by 
cloning after  short-term  treatment with  5'-bromodeoxyuridine (BrdU).  The 
variants  (mutants)  were  analyzed for  tumorigenic potential in vivo and for 
several  markers of  viral activity in vitro.  The  relationship of  these  markers 
(cell morphology, chromosome number, production of virion antigens, rescu- 
ability of sarcoma genome) to in vivo activity has been determined for a number 
of variants. The results of these studies are presented in this and the following 
report. 
Materials and Methods 
Cell lines.--The clonal lines BALB/3T3, clone A31, and the Ki-MSV transformed subclone 
of this line, K-234 (NP), were obtained from Dr. G. Todaro and S. Aaronson, National Cancer 
Institute, Bethesda, Md. They were maintained in Eagle's medium (MEM) with 10% fetal 
bovine serum and antibiotics. The BALB/3T3  cell line is contact inhibited, aneuploid, and 
nontumorigenic (2). The NP cell line is not contact inhibited, and is highly tumorigenic in 
immunocompetent BALB/c mice (2). NP cells do not replicate virus, but do contain  the 
murine sarcoma genome which can be rescued by superinfection of the  cells with  murine 
leukemia virus (1). 
BrdU Treatment.--4 X 10 a cells were plated per 50 mm diameter Falcon plastic petri dish 
(Falcon Plastic, Div. of BioQuest, Oxnard, Calif.). 24 h later the fluid was changed and BrdU 
(20/zg/mI) was added. The cultures were grown for 24-48 h with BrdU, washed to remove the 
BrdU;  fresh media was then added and the  cells further  cultivated  for several days.  The 
treated cells were trypsinized, and approximately 102 cells seeded per plate in order to isolate 
possible mutants. Each of the clones isolated initially  was recloned by single cell plating several 
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additional times. Those colonies which were composed mainly of flat cells were chosen for the 
studies described here. 
Tumorigenicity Test.--104-106 cells in 0.2 ml of MEM were inoculated subcutaneously into 
25-35-day old BALB/c mice. The mice were palpated three times per week for 50 days. The 
progressively growing tumors, which were  obtained with several of  the cell lines, weighed 
½-2 g  at this time, while palpable but nonprogressively growing  tumors reached  less than 
0.1 g wet weight. The tumors were also observed histologically. 
Electron Microscopy.--Shedding  of Type C  viruses was observed by electron microscopy. 
Cultures were fixed in situ for 30 mill with cold 1% gluteraldehyde, buffered at pH 7.2. Cells 
were scraped, pelleted by low speed centrifugation, washed thoroughly with phosphate buffer, 
pH  7.2,  fixed for 30 min at 4°C with 1% osmium tetroxide,  dehydrated with ethanol, and 
embedded in epoxy resin (Epon-812). This sections were stained with uranyl acetate and lead 
citrate  and  examined  in  a  Hitachi  HU-11E  electron  microscope  (Hitachi  America Ltd., 
Indianapolis, Ind.). 
RESULTS 
Each presumptive mutant cell line was tested for two markers; tumorigenesis 
in syngeneic BALB/c mice, and production of Type C particles. Based on these 
two properties, the mutants could be classified into four groups: (A) tumorigenic, 
without particles; (B) tumorigenic, with Type C particles; (C) nontumorigenic, 
without particles; and (D) nontumorigenic, with Type C particles, Examples of 
the mutants in each group are shown in Fig. 1. 
When  the  tumorigenic progenitor NP  cells  were inoculated into BALB/c 
mice,  106  cells  produced  a  100%  incidence of progressively growing tumors 
which resulted in death of the host animals within 15-20  days. Clone M-50 in 
group A, and clone M-57-1  in group B revealed oncogenic potential similar to 
the NP cells as indicated in Fig. 2. In contrast, the normal progenitor BALB/ 
3T3 and clones of groups C and D  formed no progressively growing tumors, 
although some mice in this particular experiment showed tiny palpable tumors 
after longer incubation periods. These nonprogressive tumors weighed less than 
0.2 g. Animals inoculated with 104-106 cells of C and D  group cell lines 00-20 
passages after the experiment shown in Fig. 2),  did not produce any palpable 
tumors in the 50 day observation period, as shown in Table I. 
Mutant 
Normal  Tumorigenic 
Progenitor--> Progenitor 




Po  s  itive 
Tumorigenicity 
Negative 
A) No Type C Particles  M-50 
B) Shedding Type C Particles  M-57-I 
C) No Type C Particles  M-43-Z 
D) Shedding Type C Particles  M-58-4 
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FIG. 2.  Tumor formation by BrdU-treated NP cells in BALB/c mice.  106 cells in 0.2  ml 
MEM were inoculated by the subcutaneous route into 35-day old BALB/c mice. Each group 
contained 6  7 animals. Cells were obtained at 15-20 passages after cloning.  Parental NP cells 
(O--O); M-50 (O--O); M-57-1  (~--~);  M-43-2  (A--A); M-584 (U--I).  +  denotes all 
animals sacrificed; =4 denotes small nonprogressive growths. 
TABLE  I 
Tumor Formation in BALB/c i~[ice 
Cell type  Cell line 
Number of cells inoculated  per animal* 
l0 G  10~  10  4 
Tumor  Average  Tumor  Average  Tumor  Average 
incidence  latency  incidence  latency  incidence  latency 
Progenitor  NP  4/4~  7§  4/4  10  2/4  14 
A  M-50  4/4  10  4//4  15  1/4  25 
B  M-57-1  4/4  8  3/3  12  2/4  15 
C  M-43-2  0/4  >50  0/4  >50  0/4  >50 
D  M-58-4  0/4  >50  0/4  >50  0/4  >50 
* The cells which had 25-30 passages after cloning were inoculated subcutaneously into 
25-day  old BALB/c mice in 0.2  ml  of MEM.  The animals  were tested  for  progressively 
growing tumors three times a week for 50 days. The latency period for tumor development 
was taken as the time when the tumors first became palpable. 
:~ Number of animals with tumors/number of animals inoculated. 
§ Days. 
Cell mutants  of each group  were microscopically examined as shown  in Fig. 
3. The normal progenitor BALB/3T3  appears  fiat and contact inhibited,  while 
the  tumorigenic  progenitor  NP  cell  appears  highly  refractile  and  round. 
Tumorigenic potential did not necessarily correspond  to morphological flatness~ 
e.g., the M-50 line appears flat despite high tumorigenic potential, while M-57-1 FIG. 3. Morphology of parental and mutant cells.  Magnification 210;<.  (a)  NP  parental 
cell; (b) M-50; (c) M-57-1; (d)  BALB/3T3; (e) M-43-2; (f)  M-58-4. 360  MUTANTS  OF  NP  CELLS 
of group B, which originally appeared flat was round, refractile, and tumorigenic 
at the time of these experiments. Both M-43-2 and M-58-4 are flat, and non- 
tumorigenic. 
The presence of Type C particles in cloned lines was investigated by electron 
microscopy. Cell lines in groups B  and D  are shown shedding typical Type C 
particles (Fig. 4). Fig. 4 a shows the M-57-1 cell line, Fig. 4 b shows the M-58-4 
cell line. Although the cell lines of group A and C did not show particles, tumor 
explants  derived from M-50 cells  (group A)  occasionally revealed intracyto- 
plasmic A  particles as  shown in  Fig.  4  c.  The M-50 cell line,  before in vivo 
transplantation did not reveal intracytoplasmic A particles. 
Tumors obtained from groups A and B show typical evidence of malignancy 
of an epithelial nature with polygonal cells,  adenomatous clustering with base- 
ment  membranes,  focal necrosis,  many mitotic  cells,  and  minimal  leukocyte 
infiltration  (Fig.  5  a,  b).  Less occasionally, cell mutants  in  groups  C  and  D 
produced small  but palpable  tumors  after a  long latent period,  without pro- 
gressive growth. The histological observation of these tumors did not indicate 
malignancy,  but  rather  a  granulomatous  reaction  with  enormous  leukocyte 
infiltration. Neither mitotic cells nor necrotic cells were found (Fig. 5 c). 
DISCUSSION 
The characteristics of each cell mutant produced by BrdU treatment of viral 
transformed NP cells remained stable for 50 passages after the initial isolation. 
It is worthwhile to note that the morphological appearance of a mutant line in 
culture did not necessarily correlate with its tumorigenic potential,  since ap- 
parent flat variants  were sometimes highly tumorigenic,  e.g.,  M-50.  Type C 
particle shedding also did not appear to be correlated with tumorigenesis, e.g., 
the M-57-1 cell line, while shedding Type C particles, was highly tumorigenic; 
whereas  M-58-4  was  not  tumorigenic despite abundant  shedding of Type C 
particles. The retention of oncogenic potential in some but not all clones in- 
duced by BrdU treatment is  contradictory to results recently obtained  with 
mouse melanoma cells treated with BrdU (3). In those experiments (3), short- 
term  or  chronic  exposure  to  BrdU  resulted  in  suppression  of  oncogenicity 
coincident with a large increase in production of virus particles. However, some 
variability was noted with time after return to normal medium. In our experi- 
ments, the oncogenic properties of the isolated cloned lines remained constant 
through multiple passages over a  6 mo period. A subsequent paper will  focus 
on the relationship between tumorigenesis and presence of the sarcoma virus 
genome in these mutant lines. 
SUMMARY 
A  variety of cell mutants were obtained by a  single 51-bromodeoxyuridine 
(BrdU) treatment of an nonproducer (NP) cell line transformed by the Kirsten 
strain  of murine sarcoma virus  (Ki-MSV).  Isolation procedures of these cell FIG. 4. Electron microscopy of mutant cell lines: (a) M-57-1 cells showing Type C particles, 
15,000M;  (b)  M-58-4 cells showing Type C  particles,  22,500M;  (c)  M-50T  cells  showing 
intracisternai A particles, 22,500X. 362  MUTANTS  OF  N~  CELLS 
FIG. 5.  Morphological appearance of tumors derived from mutant cell lines.  Cells stained 
with  Giemsa.  Magnification  77X  (left-hand  panel);  187X  (right-hand  panel).  Top  (a,  d) 
M-50  epithelial  tumor;  middle  (b,  e)  M-57-1,  carcinomatous  appearance;  bottom  (c, f) 
M-58-4,  granulomatous appearance. HATANAKA,  KLEIN,  TONI,  WALKER,  AND  GILDEN  363 
mutants are described. The cell mutants obtained were classified by tumorigenic 
potential and shedding of Type C virus particles. The cell mutants were classi- 
fied into four groups:  (A) tumorigenic, without particles; (B) tumorigenic, with 
Type C  particles;  (C)  nontumorigenic,  without particles;  and (D)nontumori- 
genic, with Type C  particles. The tumorigenic cell lines showed variability in 
morphology with both flat and typical transformed appearing cell lines showing 
equal transplantability. 
The authors thank Dr. Y. Ikawa for valuable comments on the histological observations. 
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